VitaNova Life Sciences (VNOV) Total Debt Growth (1y) (2020 - 2025)
VitaNova Life Sciences (VNOV) Total Debt Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 0.00% |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 15.82% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 57.65% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 16.11% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -16.68% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 8.00% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 1,019.83% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 18.04% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.12% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 135.17% |
| Oct 31, 2024 | 688.32% |
| Apr 30, 2024 | -81.37% |
| Jan 31, 2024 | 169.39% |
| Oct 31, 2023 | 34.19% |
| Apr 30, 2023 | 33.06% |
| Jan 31, 2023 | 33.06% |
| Oct 31, 2022 | 0.00% |
| Apr 30, 2022 | -91.72% |
| Jan 31, 2022 | -91.72% |
| Oct 31, 2021 | -91.00% |
| Apr 30, 2021 | 40.73% |
| Jan 31, 2021 | 64.12% |
| Oct 31, 2020 | 64.28% |
| Jul 31, 2020 | 48.05% |
| Apr 30, 2020 | 106.64% |